Sol-Gel Technologies Ltd. SEC filings SLGL

Sol-Gel Technologies Ltd. has 329 filings in SEC EDGAR's recent list, going back to Sep 28, 2016. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 6, 2026. The company's fiscal year ends on December 31.

Sol-Gel Technologies Ltd. SEC filings
Form Description Filed Period
EFFECT Filing Mar 23, 2026 —
EFFECT Filing Aug 18, 2025 —
EFFECT Filing May 8, 2025 —
CORRESP Letter to the SEC May 6, 2025 —
UPLOAD Letter from the SEC May 2, 2025 —
EFFECT Filing Apr 30, 2025 —
EFFECT Filing Apr 1, 2024 —
EFFECT Filing May 5, 2023 —
CORRESP Letter to the SEC May 3, 2023 —
UPLOAD Letter from the SEC Mar 17, 2023 —
EFFECT Filing Apr 13, 2022 —
CORRESP Letter to the SEC Apr 11, 2022 —
UPLOAD Letter from the SEC Apr 8, 2022 —
EFFECT Filing Apr 12, 2019 —
CORRESP Letter to the SEC Apr 10, 2019 —
UPLOAD Letter from the SEC Apr 4, 2019 —
EFFECT Filing Jan 31, 2018 —
CT ORDER Filing Jan 31, 2018 —
CERT Filing Jan 31, 2018 —
UPLOAD Letter from the SEC Jan 29, 2018 —
CORRESP Letter to the SEC Jan 29, 2018 —
CORRESP Letter to the SEC Jan 29, 2018 —
8-A12B Filing Jan 26, 2018 —
CORRESP Letter to the SEC Jan 17, 2018 —
UPLOAD Letter from the SEC Jan 16, 2018 —
CORRESP Letter to the SEC Dec 29, 2017 —
UPLOAD Letter from the SEC Sep 11, 2017 —
CORRESP Letter to the SEC Sep 1, 2017 —
CORRESP Letter to the SEC Aug 29, 2017 —
UPLOAD Letter from the SEC Aug 28, 2017 —
DRS/A Filing Aug 11, 2017 —
DRSLTR Filing Jun 6, 2017 —
DRS/A Filing Jun 6, 2017 —
UPLOAD Letter from the SEC May 1, 2017 —
DRSLTR Filing Apr 3, 2017 —
DRS/A Filing Apr 3, 2017 —
UPLOAD Letter from the SEC Oct 27, 2016 —
DRS Filing Sep 28, 2016 —

Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SLGL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ness Ziona
SEC filer status
Non-accelerated filer
SEC CIK
1684693

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.